Treatment Information

Back

Bladder Cancer treatment details. Biologic therapy.

Lukas Hospital, Neuss, Germany.

Survival: monthsCountry:Germany
Toxiciy Grade:4City/State/Province:Neuss
Treatments:Biologic therapyHospital:Lukas Hospital
Drugs:Journal:Link
Date:Dec 2012

Description:

Patients:
This phase 2 study involved 15 metastatic urothelial carcinoma patients who had been previously treated with platinum-based chemotherapy. The median patient age was 64.7 years and 71% were male.

Treatment:
Patients were treated with temsirolimus, a biologic therapy agent that inhibits the mTOR protein to cause cancer cell death.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 fatigue, thrombocytopenia, and neutropenia.

Results:
The median overall survival was 3.5 months.

Correspondence: Dr. Holger Gerullis ; email: [email protected]



Back